Iranians enduring the latest communications shutdown warn that it’s crippling businesses. Critics say officials flagrantly ...
Lung01 Phase 2 trial, with support from IDeate-PanTumor01 Phase 1/2 trialIf approved, ifinatamab deruxtecan would be a first-in-class B7-H3 directed DXd antibody drug conjugate for these patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results